Oct 27, 2021 7:00am EDT Recro Enters Into Master Commercial Supply and Services Agreement With Otsuka
Oct 20, 2021 7:00am EDT Recro Awarded Development and Manufacturing Contract by National Institutes of Health (NIH) to Support Novel Nasal Spray Analgesic
Sep 08, 2021 7:00am EDT Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Aug 13, 2021 8:50am EDT Recro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMO
Aug 10, 2021 7:00am EDT Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO